Intravenous Immunoglobulins for the Treatment of Primary Sjögren's Syndrome Associated Painful Sensory Neuropathies
Clinical trial NCT03700138 · COMPLETED
Trial details
- NCT number
- NCT03700138
- Sponsor
- University Hospital, Strasbourg, France
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-19
- Primary completion
- 2025-04-10
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.